Fansheng Meng , Yiheng Zhang , Xujing Gu , Tianle Ma , Zhipeng Chen , Huihua Fang , Li Wu , Huaning Xu , Yan Huang
{"title":"枸橼酸钠通过调节乳酸代谢和抑制调节性t细胞分化对肝癌的抑制作用","authors":"Fansheng Meng , Yiheng Zhang , Xujing Gu , Tianle Ma , Zhipeng Chen , Huihua Fang , Li Wu , Huaning Xu , Yan Huang","doi":"10.1016/j.eujim.2025.102545","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Wogonin, an active flavonoid derived from the traditional Chinese medicinal herb Scutellaria baicalensis, has been reported to regulate cellular metabolism. Increasing evidence suggests that wogonin inhibits regulatory T-cell (Treg) differentiation and modulates immune responses both <em>in vitro</em> and <em>in vivo</em>. However, the underlying molecular mechanisms remain poorly understood. Our previous findings demonstrated that lactic acid, a metabolic byproduct of glycolysis in hepatocellular carcinoma (HCC) cells, promotes the differentiation of naïve CD4<sup>+</sup> <em>T</em> cells into Tregs.</div></div><div><h3>Methods</h3><div>The effects of wogonin (1.25, 5, and 20 μg/mL) on naïve CD4<sup>+</sup> <em>T</em>-cell differentiation were examined in the presence of lactic acid. The proportion of Tregs was analyzed using flow cytometry. Protein and mRNA expression levels of TGF-β, p-Smad2, p-Smad3, LDHA, p-mTOR, HIF-1α, ATP5B, and FOXP3 were measured by western blotting (WB) and RT-PCR, respectively. Levels of IL-10, α-KG, and 2-HG were quantified using ELISA. To further assess <em>in vivo</em> efficacy, a mouse hepatoma transplantation model was established by subcutaneous injection of H22 cells. Seven days after inoculation, mice were treated with wogonin (12.5 or 25 mg/kg). After three weeks, mice were euthanized. Tumors underwent histological analysis by HE staining, while CD4<sup>+</sup>and CD8<sup>+</sup> <em>T</em>-cell populations were assessed via immunohistochemistry and flow cytometry. LDHA enzyme activity, intracellular and extracellular lactate and glucose concentrations were measured by ELISA. FOXP3 and IL-10 mRNA levels were evaluated by RT-PCR.</div></div><div><h3>Results</h3><div>Supplemental lactic acid significantly increased Treg differentiation following cytokine stimulation (anti-CD3, anti-CD28, and TGF-β). Conversely, wogonin treatment significantly and dose-dependently reduced Treg differentiation and LDHA expression. Through inhibitor screening, c-Myc was identified as a critical molecular target of wogonin. Mechanistically, wogonin suppressed c-Myc activity, subsequently downregulating LDHA expression and enzyme activity, reducing abnormal accumulation of 2-hydroxyglutarate (2-HG), normalizing the 2-HG/α-KG ratio, and ultimately decreasing FOXP3 and IL-10 expression.</div></div><div><h3>Conclusions</h3><div>Wogonin suppresses Treg differentiation and exerts anti-HCC effects by inhibiting c-Myc-mediated LDHA expression and disrupting the 2-HG/ATP5B/mTOR/HIF-1α signaling pathway. Given its potential to reshape the immunosuppressive tumor microenvironment, further investigation into its combination with PD-1/PD-L1 inhibitors is warranted.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102545"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Inhibitory effects of wogonin on hepatocellular carcinoma through modulation of lactate metabolism and suppression of regulatory T-cell differentiation\",\"authors\":\"Fansheng Meng , Yiheng Zhang , Xujing Gu , Tianle Ma , Zhipeng Chen , Huihua Fang , Li Wu , Huaning Xu , Yan Huang\",\"doi\":\"10.1016/j.eujim.2025.102545\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Wogonin, an active flavonoid derived from the traditional Chinese medicinal herb Scutellaria baicalensis, has been reported to regulate cellular metabolism. Increasing evidence suggests that wogonin inhibits regulatory T-cell (Treg) differentiation and modulates immune responses both <em>in vitro</em> and <em>in vivo</em>. However, the underlying molecular mechanisms remain poorly understood. Our previous findings demonstrated that lactic acid, a metabolic byproduct of glycolysis in hepatocellular carcinoma (HCC) cells, promotes the differentiation of naïve CD4<sup>+</sup> <em>T</em> cells into Tregs.</div></div><div><h3>Methods</h3><div>The effects of wogonin (1.25, 5, and 20 μg/mL) on naïve CD4<sup>+</sup> <em>T</em>-cell differentiation were examined in the presence of lactic acid. The proportion of Tregs was analyzed using flow cytometry. Protein and mRNA expression levels of TGF-β, p-Smad2, p-Smad3, LDHA, p-mTOR, HIF-1α, ATP5B, and FOXP3 were measured by western blotting (WB) and RT-PCR, respectively. Levels of IL-10, α-KG, and 2-HG were quantified using ELISA. To further assess <em>in vivo</em> efficacy, a mouse hepatoma transplantation model was established by subcutaneous injection of H22 cells. Seven days after inoculation, mice were treated with wogonin (12.5 or 25 mg/kg). After three weeks, mice were euthanized. Tumors underwent histological analysis by HE staining, while CD4<sup>+</sup>and CD8<sup>+</sup> <em>T</em>-cell populations were assessed via immunohistochemistry and flow cytometry. LDHA enzyme activity, intracellular and extracellular lactate and glucose concentrations were measured by ELISA. FOXP3 and IL-10 mRNA levels were evaluated by RT-PCR.</div></div><div><h3>Results</h3><div>Supplemental lactic acid significantly increased Treg differentiation following cytokine stimulation (anti-CD3, anti-CD28, and TGF-β). Conversely, wogonin treatment significantly and dose-dependently reduced Treg differentiation and LDHA expression. Through inhibitor screening, c-Myc was identified as a critical molecular target of wogonin. Mechanistically, wogonin suppressed c-Myc activity, subsequently downregulating LDHA expression and enzyme activity, reducing abnormal accumulation of 2-hydroxyglutarate (2-HG), normalizing the 2-HG/α-KG ratio, and ultimately decreasing FOXP3 and IL-10 expression.</div></div><div><h3>Conclusions</h3><div>Wogonin suppresses Treg differentiation and exerts anti-HCC effects by inhibiting c-Myc-mediated LDHA expression and disrupting the 2-HG/ATP5B/mTOR/HIF-1α signaling pathway. Given its potential to reshape the immunosuppressive tumor microenvironment, further investigation into its combination with PD-1/PD-L1 inhibitors is warranted.</div></div>\",\"PeriodicalId\":11932,\"journal\":{\"name\":\"European Journal of Integrative Medicine\",\"volume\":\"78 \",\"pages\":\"Article 102545\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Integrative Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1876382025000940\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Integrative Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876382025000940","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
Inhibitory effects of wogonin on hepatocellular carcinoma through modulation of lactate metabolism and suppression of regulatory T-cell differentiation
Introduction
Wogonin, an active flavonoid derived from the traditional Chinese medicinal herb Scutellaria baicalensis, has been reported to regulate cellular metabolism. Increasing evidence suggests that wogonin inhibits regulatory T-cell (Treg) differentiation and modulates immune responses both in vitro and in vivo. However, the underlying molecular mechanisms remain poorly understood. Our previous findings demonstrated that lactic acid, a metabolic byproduct of glycolysis in hepatocellular carcinoma (HCC) cells, promotes the differentiation of naïve CD4+T cells into Tregs.
Methods
The effects of wogonin (1.25, 5, and 20 μg/mL) on naïve CD4+T-cell differentiation were examined in the presence of lactic acid. The proportion of Tregs was analyzed using flow cytometry. Protein and mRNA expression levels of TGF-β, p-Smad2, p-Smad3, LDHA, p-mTOR, HIF-1α, ATP5B, and FOXP3 were measured by western blotting (WB) and RT-PCR, respectively. Levels of IL-10, α-KG, and 2-HG were quantified using ELISA. To further assess in vivo efficacy, a mouse hepatoma transplantation model was established by subcutaneous injection of H22 cells. Seven days after inoculation, mice were treated with wogonin (12.5 or 25 mg/kg). After three weeks, mice were euthanized. Tumors underwent histological analysis by HE staining, while CD4+and CD8+T-cell populations were assessed via immunohistochemistry and flow cytometry. LDHA enzyme activity, intracellular and extracellular lactate and glucose concentrations were measured by ELISA. FOXP3 and IL-10 mRNA levels were evaluated by RT-PCR.
Results
Supplemental lactic acid significantly increased Treg differentiation following cytokine stimulation (anti-CD3, anti-CD28, and TGF-β). Conversely, wogonin treatment significantly and dose-dependently reduced Treg differentiation and LDHA expression. Through inhibitor screening, c-Myc was identified as a critical molecular target of wogonin. Mechanistically, wogonin suppressed c-Myc activity, subsequently downregulating LDHA expression and enzyme activity, reducing abnormal accumulation of 2-hydroxyglutarate (2-HG), normalizing the 2-HG/α-KG ratio, and ultimately decreasing FOXP3 and IL-10 expression.
Conclusions
Wogonin suppresses Treg differentiation and exerts anti-HCC effects by inhibiting c-Myc-mediated LDHA expression and disrupting the 2-HG/ATP5B/mTOR/HIF-1α signaling pathway. Given its potential to reshape the immunosuppressive tumor microenvironment, further investigation into its combination with PD-1/PD-L1 inhibitors is warranted.
期刊介绍:
The European Journal of Integrative Medicine (EuJIM) considers manuscripts from a wide range of complementary and integrative health care disciplines, with a particular focus on whole systems approaches, public health, self management and traditional medical systems. The journal strives to connect conventional medicine and evidence based complementary medicine. We encourage submissions reporting research with relevance for integrative clinical practice and interprofessional education.
EuJIM aims to be of interest to both conventional and integrative audiences, including healthcare practitioners, researchers, health care organisations, educationalists, and all those who seek objective and critical information on integrative medicine. To achieve this aim EuJIM provides an innovative international and interdisciplinary platform linking researchers and clinicians.
The journal focuses primarily on original research articles including systematic reviews, randomized controlled trials, other clinical studies, qualitative, observational and epidemiological studies. In addition we welcome short reviews, opinion articles and contributions relating to health services and policy, health economics and psychology.